Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Asymchem Laboratories Tianjin (002821 CH)
Watchlist
72
Analysis
Health Care
•
China
Asymchem Laboratories (Tianjin) Co., Ltd. operates as a pharmaceutical company. The Company researches, produces, and sells organic and inorganic chemicals, medicines, and other related products. Asymchem Laboratories serves customers worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
China Tourism Group Duty Free
•
24 Aug 2022 09:51
China Tourism Group A/H Trading - Decent Support from Long-Only but Minimal Retail Participation
China Tourism Group Duty Free Corporation Limited (CDF) raised around US$2.4bn in its H-share listing in Hong Kong, after pricing its IPO at HKD158...
Sumeet Singh
Follow
354 Views
Share
bullish
•
Tencent
•
21 Aug 2022 07:10
ECM Weekly (21st Aug 2022) - China Tourism, SoCar, Beauty Farm, ANZ, Max, Judo, Steadfast, Cleanaway
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
Sumeet Singh
Follow
469 Views
Share
bearish
•
China Tourism Group Duty Free Corp Ltd
•
11 Aug 2022 11:58
Past A/H Listings Performance - Most of the Deals Haven’t Done Much
China Tourism is gearing up to launch Hong Kong’s largest listing so far this year, with a reported deal size of around US$2-3bn. Ahead of its...
Sumeet Singh
Follow
427 Views
Share
bullish
•
Tianqi Lithium
•
12 Jul 2022 09:39
Tianqi Lithium A/H Trading - A-Shares Have Done Relatively Well, H-Shares Should Follow
Tianqi Lithium (TL) raised around US$2bn via its H-shares listing. In this note, we talk about the updates since our last notes, along with the...
Sumeet Singh
Follow
440 Views
Share
bullish
•
Quantitative Analysis
•
02 May 2022 09:55
A-H Premium Weekly: Asymchem Lab, China Comm Construction
We highlight weekly A-H premium changes of Asymchem Lab, China Comm Construction, Conch Cement, Zhesheng Bank, Anhui Express, and CICITC Securities.
Ke Yan, CFA, FRM
Follow
262 Views
Share
First
Previous
4
5
6
7
8
9
10
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x